SEC Filings

Form S-3
PROTAGONIST THERAPEUTICS, INC filed this Form S-3 on 09/01/2017
Document Outline
Entire Document (1353.5 KB)
Subdocument 1 - S-3 - S-3
Page 1 - As filed with the Securities and Exchange Commission on September 1, 2017
Page 2 - EXPLANATORY NOTE
Page 3 - The information contained in this prospectus is not complete and may be changed. We may not sell the
Page 4 - TABLE OF CONTENTS
Page 5 - N/A
Page 6 - SUMMARY
Page 7 - Janssen Collaboration Agreement
Page 8 - Company Information
Page 9 - THE SECURITIES WE MAY OFFER
Page 10 - Preferred Stock.
Page 11 - N/A
Page 12 - RISK FACTORS
Page 13 - N/A
Page 14 - FINANCIAL RATIOS
Page 15 - DESCRIPTION OF CAPITAL STOCK
Page 16 - N/A
Page 17 - Options
Page 18 - Form S-3 registration rights
Page 19 - Staggered Board
Page 20 - Transfer Agent and Registrar
Page 21 - DESCRIPTION OF DEBT SECURITIES
Page 22 - N/A
Page 23 - Conversion or Exchange Rights
Page 24 - N/A
Page 25 - Modification of Indenture; Waiver
Page 26 - Discharge
Page 27 - Information Concerning the Trustee
Page 28 - LEGAL OWNERSHIP OF SECURITIES
Page 29 - Legal Holders
Page 30 - Special Considerations for Global Securities
Page 31 - N/A
Page 32 - PLAN OF DISTRIBUTION
Page 33 - N/A
Page 34 - N/A
Page 35 - LEGAL MATTERS
Page 36 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 37 - The information contained in this prospectus is not complete and may be changed. We may not sell the
Page 38 - TABLE OF CONTENTS
Page 39 - N/A
Page 40 - PROSPECTUS SUMMARY
Page 41 - Janssen Collaboration Agreement
Page 42 - Company Information
Page 43 - THE OFFERING
Page 44 - RISK FACTORS
Page 45 - FORWARD-LOOKING STATEMENTS
Page 46 - USE OF PROCEEDS
Page 47 - DILUTION
Page 48 - N/A
Page 49 - DESCRIPTION OF CAPITAL STOCK
Page 50 - Options
Page 51 - Anti-Takeover Effects of Our Charter Documents and Some Provisions of Delaware Law
Page 52 - Delaware Anti-Takeover Statute
Page 53 - PLAN OF DISTRIBUTION
Page 54 - LEGAL MATTERS
Page 55 - N/A
Page 56 - Up to $50,000,000 of Shares
Page 57 - PART II
Page 58 - Item 16. Exhibits and Financial Statement Schedules
Page 59 - Item 17. Undertakings
Page 60 - Provided, however,
Page 61 - N/A
Page 62 - EXHIBIT INDEX
Page 63 - SIGNATURES
Page 64 - N/A
Subdocument 2 - EX-1.2 - EX-1.2
Page 1 - Exhibit 1.2
Page 2 - Prospectus Supplement
Page 3 - Section 12
Page 4 - Section 4
Page 5 - Representations and Warranties of the Company
Page 6 - No Misstatement or Omission
Page 7 - Conformity with EDGAR Filing
Page 8 - No Violation or Default
Page 9 - Authorization; Enforceability
Page 10 - Accountant
Page 11 - Regulatory Filings
Page 12 - Clinical Studies
Page 13 - Environmental Laws
Page 14 - Evaluation Date
Page 15 - Off-Balance Sheet Transaction
Page 16 - Insurance
Page 17 - No Conflicts
Page 18 - Stock Transfer Taxes
Page 19 - Emerging Growth Company
Page 20 - Section 7(a)
Page 21 - provided
Page 22 - Due Diligence Cooperation
Page 23 - Investment Company Act
Page 24 - Secretary s Certificate; Further Documentation
Page 25 - Conditions to the Agent s Obligations
Page 26 - Legal Opinions
Page 27 - Indemnification and Contribution
Page 28 - Agent Information
Page 29 - Contribution
Page 30 - Section 10(e)
Page 31 - Section 10
Page 32 - Business Day
Page 33 - THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY,
Page 34 - Definitions
Page 35 - Rule 164
Page 36 - N/A
Page 37 - N/A
Page 38 - SCHEDULE 1
Page 39 - SCHEDULE 2
Page 40 - SCHEDULE 3
Page 41 - SCHEDULE 4
Page 42 - Form of Representation Date Certificate Pursuant to Section 7(l)
Page 43 - Form of Legal Opinion Pursuant to Section 7(m)
Page 44 - Exhibit 21
Subdocument 3 - EX-4.5 - EX-4.5
Page 1 - Exhibit 4.5
Page 2 - TABLE OF CONTENTS
Page 3 - TABLE OF CONTENTS
Page 4 - TABLE OF CONTENTS
Page 5 - TABLE OF CONTENTS
Page 6 - Board Resolution
Page 7 - herein
Page 8 - Person
Page 9 - Trustee
Page 10 - N/A
Page 11 - N/A
Page 12 - Section 2.02
Page 13 - Section 2.04
Page 14 - Section 2.05
Page 15 - Section 2.07
Page 16 - Section 2.08
Page 17 - Section 2.11
Page 18 - Section 2.12
Page 19 - (b)
Page 20 - (b)
Page 21 - ARTICLE 4
Page 22 - Section 4.03
Page 23 - Section 4.04
Page 24 - ARTICLE 6
Page 25 - (b)
Page 26 - (b)
Page 27 - Section 6.03
Page 28 - Section 6.05
Page 29 - Section 6.07
Page 30 - (b)
Page 31 - (vii)
Page 32 - (g)
Page 33 - (b)
Page 34 - Section 7.10
Page 35 - (c)
Page 36 - (c)
Page 37 - Section 7.13
Page 38 - Section 8.02
Page 39 - Section 8.05
Page 40 - (e)
Page 41 - Section 9.03
Page 42 - (c)
Page 43 - Section 11.03
Page 44 - ARTICLE 13
Page 45 - Section 13.05
Page 46 - Section 13.08
Page 47 - Section 13.13
Page 48 - IN WITNESS WHEREOF
Page 49 - CROSS-REFERENCE TABLE (1)
Subdocument 4 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - DGCL
Page 3 - N/A
Page 4 - Page Four We hereby consent to the filing of this opinion as an exhibit to the Registration Statemen
Subdocument 5 - EX-12.1 - EX-12.1
Page 1 - Exhibit 12.1
Subdocument 6 - EX-23.1 - EX-23.1
Page 1 - Exhibit 23.1
Page 2 - N/A